Transfection Reagents & Equipment Market by Product, Method, Application, End User

Description

List of Tables

[193 Pages Report] The Transfection Reagents & Equipment Market size was estimated at USD 2.48 billion in 2023 and expected to reach USD 2.79 billion in 2024, at a CAGR 12.76% to reach USD 5.76 billion by 2030.

Transfection reagents & equipment are pivotal in the field of molecular and cellular biology, facilitating the introduction of nucleic acids into cells. This process is essential for research and development in genetics, protein production, and therapeutic drug development. The global market for transfection reagents and equipment is expanding, driven by the growth in biologics production, the rising demand for synthetic genes, and advancements in cell research. Increased research activities in biotherapeutics, along with rising investments in biotechnology and pharmaceutical R&D, are driving market growth. Continuous expansion of the gene therapy sector and the development of novel vaccines are expanding the usage of transfection reagents & equipment. The high cost of transfection reagents and sophisticated equipment and certain limitations in transfection efficiency and survival rates in some cell types hampers the market growth. Technological advancements in transfection methods for higher efficiency and lower cytotoxicity and the rising development of novel, low-toxicity transfection reagents that can efficiently transfect a wide range of cell types are expected to create opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023]	USD 2.48 billion
Estimated Year [2024]	USD 2.79 billion
Forecast Year [2030]	USD 5.76 billion
CAGR (%)	12.76%

Product: Growing usage of transfection reagents to facilitate or enhance the delivery of genetic materials

Transfection equipment plays a pivotal role in delivering genetic material into cells. This segment typically includes electroporators, bioreactors, and other physical or mechanical systems designed to facilitate the efficient and controlled introduction of nucleic acids into cells. Reagents are chemicals or formulations used in transfection procedures to facilitate or enhance the delivery of genetic material into cells. Common types include lipid-based, calcium phosphate, and viral vectors, each offering distinct advantages depending on the transfection target. Different experimental setups require specific types of equipment. Electroporation systems are preferred for their high-efficiency transfection of difficult-to-transfect cell lines and primary cells, while bioreactors offer an advantage in large-scale transfections for therapeutic manufacturing. Lipid-based reagents are widely used for their versatility and ease of use across a broad range of cell types, whereas calcium phosphate is cost-effective for transfecting adherent cells in high-throughput applications.

End User: High potential of transfection reagents & equipment across pharmaceutical & biotechnology companies for the development of vaccines and gene therapies

Academic & research institutes primarily focus on the advancement of scientific research in various fields, including genetics, molecular biology, and biochemistry. For these institutions, transfection reagents and equipment are crucial for experimental and research purposes, particularly in gene expression studies, cloning, and protein production. They often prefer cost-effective, reliable, and easy-to-use solutions that can yield high-efficiency transfection rates without compromising cell viability. Safety and reproducibility are also key considerations. For pharmaceutical & biotechnology companies, transfection technologies are instrumental in drug discovery, therapeutic research, and the development of vaccines and gene therapies. These entities prioritize high-throughput capabilities, scalability, and precision. The focus is on obtaining consistent and reproducible results that can expedite the R&D process and lead to successful commercial applications. Regulatory compliance and scalability for clinical trials are additional critical factors.

Regional Insights

In the Americas, the need for transfection reagents & equipment is driven by a strong emphasis on research and development in the biotechnology and pharmaceutical sectors. Customers in these regions prioritize quality and efficiency, seeking out the latest high-throughput transfection technologies to accelerate drug discovery and genetic research processes. Investments in personalized medicine and gene therapy projects are substantial, aiming to cater to the increasing consumer need for tailored healthcare solutions. European Union (EU) countries stand out for their regulatory leadership in genetic research and strict quality standards for transfection experiments. This has fostered a market environment where collaboration between academic institutions and the biotech industry flourishes, driving forward the development of innovative transfection technologies. The Middle East & Africa show a growing interest in transfection technologies, mainly due to the increasing investment in healthcare and education sectors. The Asia-Pacific region, including China, Japan, and India, presents a dynamic and rapidly expanding market for transfection reagents & equipment market with massive investment in biotechnology research, a burgeoning pharmaceutical industry, and a surge in genetic studies aimed at addressing prevalent local diseases. China is at the forefront, with significant government backing for biotech initiatives and a growing number of patents related to novel transfection techniques, such as CRISPR-based genome editing tools. Japan and India also show substantial market growth potential, driven by research in regenerative medicine and vaccines.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Transfection Reagents & Equipment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Transfection Reagents & Equipment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Transfection Reagents & Equipment Market, highlighting leading vendors and their innovative profiles. These include Active Motif, Inc., Agilent Technologies, Inc., Altogen Biosystems, Applied Biological Materials Inc., Bex Co., Ltd., Bio-Rad Laboratories, Inc., BioVision, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Fugent, LLC, GeneCopoeia, Inc., IBA Lifesciences GmbH, Lonza Group Ltd., MaxCyte, Inc., Merck KGaA, Mirus Bio LLC, Omega Bio-tek, Inc., OriGene Technologies Inc., PerkinElmer, Inc., Polyplus-Transfection SA by Sartorius AG, Promega Corporation, Qiagen N.V., Sartorius AG, SBS Genetech Co., Ltd., Sutter Instrument Co., Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., and TransGen Biotech Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Transfection Reagents & Equipment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Equipment
- Reagents

Method
- Biochemical Methods
  - Calcium Phosphate
  - Deae-Dextran
  - Dendrimers
  - Lipofection

Physical Methods
- Electroporation
- Genegun
- Magnetofection
- Nucleofection
- Optoinjection
- Sonoporation

Viral Methods
- Adenoassociated Viruses
- Adenoviruses
- Retroviruses

Application
- Biomedical Research
- Protein Production
- Therapeutic Delivery

End User
- Academics & Research Institutes
- Pharmaceutical & Biotechnology Companies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Transfection Reagents & Equipment Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Transfection Reagents & Equipment Market?

3. What are the technology trends and regulatory frameworks in the Transfection Reagents & Equipment Market?

4. What is the market share of the leading vendors in the Transfection Reagents & Equipment Market?

5. Which modes and strategic moves are suitable for entering the Transfection Reagents & Equipment Market?

Product Code: MRR-031685195779

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising Research Activities in the Field of Cell Science
  - 5.1.1.2. Growing Prevalence of Cancer Worldwide
  - 5.1.1.3. Large-Scale Transfection of Mammalian Cells for the Faster Generation of Recombinant Protein
- 5.1.2. Restraints
  - 5.1.2.1. Effect of Serum in Media and Cell Confluency on Efficiency of Transfection
- 5.1.3. Opportunities
  - 5.1.3.1. Recent Advancements in Transfection Technology
  - 5.1.3.2. Increasing R&D and Facility Expansion Activities by Pharmaceutical and Biotech Companies
- 5.1.4. Challenges
  - 5.1.4.1. Maintenance of Higher Level of Biological Safety
5.2. Market Segmentation Analysis
- 5.2.1. Product: Growing usage of transfection reagents to facilitate or enhance the delivery of genetic materials
- 5.2.2. End User: High potential of transfection reagents & equipment across pharmaceutical & biotechnology companies for the development of vaccines and gene therapies
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization

6. Transfection Reagents & Equipment Market, by Product

6.1. Introduction
6.2. Equipment
6.3. Reagents

7. Transfection Reagents & Equipment Market, by Method

7.1. Introduction
7.2. Biochemical Methods
7.3. Physical Methods
7.4. Viral Methods

8. Transfection Reagents & Equipment Market, by Application

8.1. Introduction
8.2. Biomedical Research
8.3. Protein Production
8.4. Therapeutic Delivery

9. Transfection Reagents & Equipment Market, by End User

9.1. Introduction
9.2. Academics & Research Institutes
9.3. Pharmaceutical & Biotechnology Companies

10. Americas Transfection Reagents & Equipment Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Transfection Reagents & Equipment Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Transfection Reagents & Equipment Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. Polyplus Launches FectoVIR-LV Transfection Reagent with New DOE Service Options
- 13.3.2. Lungs-Targeted Transfection Reagent Offers Safe and Effective Delivery of Biomolecules
- 13.3.3. Sartorius to Acquire Polyplus to Strengthen its Position in the Cell and Gene Therapy Market

14. Competitive Portfolio

14.1. Key Company Profiles
14.2. Key Product Portfolio